VisionLink – New learning through sight

Vision Link Behavioural Optometrists provide research based treatment for convergence insufficiency, oculomotor dysfunction, spelling and reading problems, dyslexia, attention deficit disorders, Aspergers, Learning Related Vision Disabilities, migraine and brain injuries. We are uniquely positioned to assist Visual Perception through the use of Vision Therapy, Irlen tinted lenses and Cellfield Intervention.

View our 3D images >>

Home > How We Help > Myopia Control > more on Myopia Control - Zeiss Myopia Control spectacle lenses

Zeiss Myopia Control spectacle lenses

The world renowned spectacle lens maker, Zeiss, has launched a new spectacle lens called MyoVision and it can slow the rate of Myopic progression for your child by as much as 30%.

The lens is a uniquely designed Single Vision lens, of different designs for the Right eye and the Left eye. It gives sharp vision in the centre but has a specially calculated degree of peripheral blur that lessens the stimulus for the eye to change shape. It is ground specially to your child's prescription.

It is based on research published by scientists from the Australian organisation "Vision Cooperative Research Centre" (Vision CRC) which partners up  the University of Houston College of Optometry and the Brien Holden Vision Institute at the University of New South Wales.

Myopia affects over 1.6 billion people and  is expected to reach 2.5 billion by 2020.

Successful basic research on the nature and cause of myopia has led to the discovery that the peripheral retinal image plays a major part in stimulating eye growth and myopia. Large scale clinical trials testing both spectacles and contact lenses designed to control the position of the peripheral image and involving over 500 children in China and Australia, have produced promising results.

This approach has been proven to be 4 times better than the use of progressive lenses to slow myopia.

The best results are achieved when the child is between the ages of 6 to 12yrs of age.

Professor Brien Holden, CEO of the Vision CRC, explained "The beauty of this new technology is that it addresses this problem by bringing the peripheral retinal image forward, onto or even in front of the retina, and at the same time independently positioning the central image on the retina giving clear vision."

The Vision CRC has also licensed its myopia control technology to CIBA VISION for contact lens applications.

Professor Holden added, "Myopia can be a serious eye condition. High myopia significantly increases the risk of cataract, glaucoma, and retinal detachment, all potentially blinding conditions and the public health risk is significant."

These lenses need to be precisely prescribed for the child, and the focus needs to be re-measured every 6 months so that the beneficial effects are maintaining their control of the shortsightedness.

Proceeding with these lenses is a significant financial commitment, but the reduction of myopia lessens the likelihood of those diseases associated with progression to a state of High Myopia (cataract, glaucoma, and retinal detachment).

Click here for technical detail and published research


or watch this embedded video.